Greg Walden, Oregon's only Republican in Congress, was one of two lawmakers who received more than $200,000 from pharmaceutical companies since January 2017.
Seema Verma, administrator for the Centers for Medicare & Medicaid, told insurance executives: “We face tremendous barriers to supporting and bringing innovation to Medicare."
Pharmacists have been prevented from telling consumers when the cash price for a drug is lower than the cost through their insurer. But critics say this will not affect the causes of high drug prices.
The country's biggest generation is shifting towards the convenience, fast service, connectivity and price transparency of walk-in clinics and telemedicine visits.